711 STEWART AVE, SUITE 200, NEW YORK, NY
ProPhase Labs Enters $2.08M Loan Agreement with J.J. Astor & Co.
ProPhase Labs Initiates Sale Process for BE-Smart™ Cancer Test
ProPhase Labs, Inc. Invites Investors to Webinar on February 3, 2026
News, Underwriting Agreement
ProPhase Labs Enters $10 Million Stock Purchase Agreement with Investor
ProPhase Labs, Inc. Uplists Common Stock to OTCID Market
Director Resignation - Warren Hirsch Steps Down from ProPhase Labs Board
Q2
Notice of Late Filing for Quarterly Report
Amended Quarterly Report
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
Prospectus filed pursuant to Rule 424(b)(5)
S-1
Prospectus filed pursuant to Rule 424(b)(3)
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
PRER14A
Notification Filed by a National Security Exchange
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
S-8 POS
Free Writing Prospectus
Post-Effective Amendment to Registration Statement